Viewing Study NCT03769103


Ignite Creation Date: 2025-12-24 @ 7:37 PM
Ignite Modification Date: 2026-02-19 @ 8:23 PM
Study NCT ID: NCT03769103
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-10-31
First Post: 2018-12-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of Osimertinib + SRS vs Osimertinib Alone for Brain Metastases in EGFR Positive Patients With NSCLC
Sponsor: British Columbia Cancer Agency
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module